These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 16460841)

  • 41. Virus and virus-like particle-based immunogens for Alzheimer's disease induce antibody responses against amyloid-beta without concomitant T cell responses.
    Chackerian B; Rangel M; Hunter Z; Peabody DS
    Vaccine; 2006 Sep; 24(37-39):6321-31. PubMed ID: 16806604
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Low-dose intraperitoneal Freund's adjuvant: toxicity and immunogenicity in mice using an immunogen targeting amyloid-beta peptide.
    Oscherwitz J; Hankenson FC; Yu F; Cease KB
    Vaccine; 2006 Apr; 24(15):3018-25. PubMed ID: 16307832
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Liposomal vaccines with conformation-specific amyloid peptide antigens define immune response and efficacy in APP transgenic mice.
    Muhs A; Hickman DT; Pihlgren M; Chuard N; Giriens V; Meerschman C; van der Auwera I; van Leuven F; Sugawara M; Weingertner MC; Bechinger B; Greferath R; Kolonko N; Nagel-Steger L; Riesner D; Brady RO; Pfeifer A; Nicolau C
    Proc Natl Acad Sci U S A; 2007 Jun; 104(23):9810-5. PubMed ID: 17517595
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Aβ vaccination in combination with behavioral enrichment in aged beagles: effects on cognition, Aβ, and microhemorrhages.
    Davis PR; Giannini G; Rudolph K; Calloway N; Royer CM; Beckett TL; Murphy MP; Bresch F; Pagani D; Platt T; Wang X; Donovan AS; Sudduth TL; Lou W; Abner E; Kryscio R; Wilcock DM; Barrett EG; Head E
    Neurobiol Aging; 2017 Jan; 49():86-99. PubMed ID: 27776266
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Development of a safe oral Abeta vaccine using recombinant adeno-associated virus vector for Alzheimer's disease.
    Hara H; Monsonego A; Yuasa K; Adachi K; Xiao X; Takeda S; Takahashi K; Weiner HL; Tabira T
    J Alzheimers Dis; 2004 Oct; 6(5):483-8. PubMed ID: 15505369
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Amyloid β 3-10 DNA vaccination suggests a potential new treatment for Alzheimer's disease in BALB/c mice.
    Xing XN; Zhang WG; Sha S; Li Y; Guo R; Wang C; Cao YP
    Chin Med J (Engl); 2011 Sep; 124(17):2636-41. PubMed ID: 22040416
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Antibody production and its neutralization of Abeta42's cytoxicity in BALB/c mice induced by Abeta42 and its subunit vaccines].
    Hu JJ; Wang HQ; Qu HG; Xu J; Yao ZB
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Mar; 20(2):178-81. PubMed ID: 15191720
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Absence of beta-amyloid deposits after immunization in Alzheimer disease with Lewy body dementia.
    Bombois S; Maurage CA; Gompel M; Deramecourt V; Mackowiak-Cordoliani MA; Black RS; Lavielle R; Delacourte A; Pasquier F
    Arch Neurol; 2007 Apr; 64(4):583-7. PubMed ID: 17420322
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunization with a new DNA vaccine for Alzheimer's disease elicited Th2 immune response in BALB/c mice by in vivo electroporation.
    Xing X; Sha S; Li Y; Zong L; Jiang T; Cao Y
    J Neurol Sci; 2012 Feb; 313(1-2):17-21. PubMed ID: 22029939
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intracerebroventricular passive immunization in transgenic mouse models of Alzheimer's disease.
    Chauhan NB; Siegel GJ
    Expert Rev Vaccines; 2004 Dec; 3(6):717-25. PubMed ID: 15606357
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Diminished amyloid-beta burden in Tg2576 mice following a prophylactic oral immunization with a salmonella-based amyloid-beta derivative vaccine.
    Boutajangout A; Goni F; Knudsen E; Schreiber F; Asuni A; Quartermain D; Frangione B; Chabalgoity A; Wisniewski T; Sigurdsson EM
    J Alzheimers Dis; 2009; 18(4):961-72. PubMed ID: 19749432
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Enhanced Th2 immunity after DNA prime-protein boost immunization with amyloid beta (1-42) plus CpG oligodeoxynucleotides in aged rats.
    Subramanian S; Divya Shree AN
    Neurosci Lett; 2008 May; 436(2):219-22. PubMed ID: 18394801
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Duration and specificity of humoral immune responses in mice vaccinated with the Alzheimer's disease-associated beta-amyloid 1-42 peptide.
    Dickey CA; Morgan DG; Kudchodkar S; Weiner DB; Bai Y; Cao C; Gordon MN; Ugen KE
    DNA Cell Biol; 2001 Nov; 20(11):723-9. PubMed ID: 11788050
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Production of anti-amyloid β antibodies in mice fed rice expressing amyloid β.
    Nojima J; Ishii-Katsuno R; Futai E; Sasagawa N; Watanabe Y; Yoshida T; Ishiura S
    Biosci Biotechnol Biochem; 2011; 75(2):396-400. PubMed ID: 21307566
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Analysis of three plasmid systems for use in DNA A beta 42 immunization as therapy for Alzheimer's disease.
    Qu BX; Lambracht-Washington D; Fu M; Eagar TN; Stüve O; Rosenberg RN
    Vaccine; 2010 Jul; 28(32):5280-7. PubMed ID: 20562015
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Active Aβ vaccination fails to enhance amyloid clearance in a mouse model of Alzheimer's disease with Aβ42-driven pathology.
    Nemirovsky A; Shapiro J; Baron R; Kompaniets A; Monsonego A
    J Neuroimmunol; 2012 Jun; 247(1-2):95-9. PubMed ID: 22498096
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Abeta42 immunization in Alzheimer's disease generates Abeta N-terminal antibodies.
    Lee M; Bard F; Johnson-Wood K; Lee C; Hu K; Griffith SG; Black RS; Schenk D; Seubert P
    Ann Neurol; 2005 Sep; 58(3):430-5. PubMed ID: 16130106
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intracerebroventricular passive immunization with anti-oligoAbeta antibody in TgCRND8.
    Chauhan NB
    J Neurosci Res; 2007 Feb; 85(2):451-63. PubMed ID: 17086547
    [TBL] [Abstract][Full Text] [Related]  

  • 59. DNA Aβ42 vaccination as possible alternative immunotherapy for Alzheimer disease.
    Rosenberg RN; Lambracht-Washington D
    JAMA Neurol; 2013 Jun; 70(6):772-3. PubMed ID: 23700123
    [No Abstract]   [Full Text] [Related]  

  • 60. Anti-Aβ antibodies induced by Aβ-HBc virus-like particles prevent Aβ aggregation and protect PC12 cells against toxicity of Aβ1-40.
    Feng G; Wang W; Qian Y; Jin H
    J Neurosci Methods; 2013 Aug; 218(1):48-54. PubMed ID: 23701997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.